Nanomedicine News

RSS

Global Nanomedicine Market to Reach $130.9 Billion by 2016

Global Information has added a business report titled ‘Nanotechnology in Medical Applications: The Global Market’ to its offering.

From Global Industry Analysts 23 Jan 2012

Novel Nanoparticles Help Advance Anti-Cancer Drug Delivery

A research team led by Kit S. Lam from UC Davis has synthesized a novel class of nanoparticles to eliminate premature release of drugs, paving the way to deliver anti-cancer drugs to tumor sites accurately and efficiently.

21 Jan 2012

Novel Nanoparticle-Based Drug Delivery System for Cancer Treatment

A research team headed by Dr. Xiao Yan Fat from Nano Med Tech based in Shanghai has developed a novel technique to create nanoparticles capable of acting like red blood cells.

20 Jan 2012

Nano Med Tech’s Chemical Process Helps Advance Medical Applications

Scientists from Nano Med Tech have developed a modified chemical method to create complex shapes, including honeycomb-like multi-chambered shapes and three dimensional boxes by hollowing nanoparticles.

20 Jan 2012

Researchers Discover Injectable Nanotherapeutics for Treating Type I Diabetes

Researchers from Children’s Hospital, Boston and Harvard University-based Wyss Institute for Biologically Inspired Engineering have discovered "smart" injectable nanotherapeutics that can be selectively programmed to transmit drugs to pancreatic cells.

17 Jan 2012

Researchers Develop Novel Nanoparticle-Based Delivery System to Supply Cancer Drugs

A research team led by Omid Farokhzad from Brigham and Women's Hospital (BWH) together with scientists from Massachusetts General Hospital and Massachusetts Institute of Technology has developed a drug delivery system for supplying a significant quantity of chemotherapeutic drugs to targeted prostate cancer cells.

12 Jan 2012

Nanocopoeia Gain Access to Analytical Tools at Saint Paul College

Nanocopoeia, Inc. a drug delivery company developing a nanotechnology-enabled portfolio of therapeutic products and the Saint Paul College announce the signing of an agreement for access to the college's laboratory s...

From Nanocopoeia Inc. 11 Jan 2012

Researchers Discover Ormosil Nanoparticles as Potential Drug Delivery Vehicle to Brain

Shermali Gunawardana, University of Buffalo researcher, discovered that ORMOSIL nanoparticles when injected into the brain of insects, which even after being exposed for a long time, did not affect the flies and cells in any way.

11 Jan 2012

Nanomedicine Company, Blend Therapeutics Announces its Founding Mission

Blend Therapeutics, a biotechnology firm founded by Dr. Omid Farokhzad, Director of Laboratory of Nanomedicine and Biomaterials at Harvard Medical School, and Dr. Stephen Lippard and Dr. Robert Langer, Professors from the Massachusetts Institute of Technology, has declared its founding mission.

10 Jan 2012

Alnylam Submits CTA for Lipid Nanoparticle-Based RNAi TTR, ALN-TTR02

Alnylam Pharmaceuticals, a company specializing in RNAi therapeutics, has announced the submission of a clinical trial application (CTA) with the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) to start a Phase I clinical study of its RNAi therapeutic targeting transthyretin (TTR) called ALN-TTR02 for treating TTR-mediated amyloidosis (ATTR).

10 Jan 2012